Research News and Research

RSS

Clinical Immunology Research Laboratory at The Mount Sinai Medical Center receives Octapharma grant

Octapharma USA today announced the second grant recipient of the Octapharma 25th Anniversary Grants Program is the Clinical Immunology Research Laboratory at The Mount Sinai Medical Center. The Octapharma Grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.

20 Jan 2011

ESHRE publishes position paper on intrafamilial medically assisted reproduction

The European Society of Human Reproduction and Embryology (ESHRE) has published today (Thursday) a position paper related to intrafamilial medically assisted reproduction (IMAR).This particular type of assisted reproduction can raise various ethical and controversial issues, due to the involvement of a family member as a third party.

20 Jan 2011

Breastfeeding can partially offset long-term side effects of cancer treatment

Women who have survived childhood cancer should be advised to breastfeed if they can, in order to offset some of the negative health effects of their earlier cancer treatment. According to Susan Ogg and colleagues from St. Jude Children's Research Hospital in Memphis, Tennessee, making women aware of the benefits of breastfeeding should be part of routine post-cancer diet and healthy lifestyle recommendations.

20 Jan 2011

Ingenix announces formation of new Life Sciences division

Ingenix, a leading provider of health care information, technology and consulting services, today announced the formation of Ingenix Life Sciences, a newly-organized division that focuses Ingenix's capabilities in assisting life sciences clients to identify, analyze and measure the value of their products.

20 Jan 2011

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

inVentiv Health, a leading provider of outsourced clinical development, launch and commercial services to the global health care industry, today announced it has signed a definitive agreement to purchase the i3 clinical development businesses from Ingenix.

20 Jan 2011

Damaged alpha-synuclein proteins can spread in a 'prion-like' manner: Study

The study, published in the Journal of Clinical Investigation, reveals that damaged alpha-synuclein proteins can spread in a 'prion-like' manner, an infection model previously described for diseases such as BSE.

20 Jan 2011

CHI responds to FDA recommendations for 510(k) regulatory review process

California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.

20 Jan 2011

NMDP selects Velos to supply new Product Fulfillment and CDR System

The National Marrow Donor Program announced today that it has selected Velos, a leading California health care software provider, to supply its new Product Fulfillment and Clinical Data Repository System.

20 Jan 2011

Merck provides additional information about DSMB recommendations for vorapaxar TRA-2P study

Merck reported today that investigators in the TRA-2P study of vorapaxar have been provided with additional information about the recommendations of the Data and Safety Monitoring Board (DSMB) regarding the TRA-2P study. The additional information was sent yesterday in a communication to investigators from the Operations Committee of the TRA-2P study of vorapaxar. Vorapaxar is one of Merck's investigational cardiovascular medicines.

20 Jan 2011

No robust conclusions possible on advantages or disadvantages of PET

Malignant gliomas are fast-growing brain tumours with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the choice of the right treatment than other procedures. In a final report the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated the benefit of PET in the detection of recurrences. According to this report, no robust conclusions are possible on the advantages or disadvantages of PET.

20 Jan 2011

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease (PVD).

20 Jan 2011

Long-term use of khat drug decreases self-control, leads to undesirable behaviour: Study

Researchers at the universities of Leiden, Amsterdam and Granada were the first to investigate the effects of the drug khat on a person's ability to inhibit undesirable behaviour.

20 Jan 2011

Message of health benefits of moderate drinking are hazardous and extremely dangerous

A Letter to the Editor entitled "What should we advise about alcohol consumption?" was recently published by Maurizio Ponz de Leon in Intern Emerg Med.1 Dr. de Leon argues that the message of health benefits of moderate drinking "seems to me hazardous and extremely dangerous to diffuse in the general population."

20 Jan 2011

Brains of migraine sufferers show higher proportion of lesions of brain microvessels

Recent work, in particular the CAMERA study, has used MRI to study the brains of migraine sufferers and has shown that a higher proportion of these patients exhibit lesions of the brain microvessels than the rest of the population.

20 Jan 2011

Ultrasound device shows promise in breaking up pulmonary embolisms: Research

A tiny ultrasound device that helps dissolve blood clots is showing promise in breaking up potentially deadly pulmonary embolisms, blockages of blood vessels in the lungs that can occur after long plane rides, surgery and extended bed rest.

20 Jan 2011

FOLOTYN Phase 2 peripheral T-cell lymphoma study results published in Journal of Clinical Oncology

Allos Therapeutics, Inc. today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

20 Jan 2011

Anaesthetising an arm affects brain activity and rapidly impairs body perception

An Inserm research team in Toulouse, led by Dr Stein Silva (Inserm Unit 825 "Brain imaging and neurological handicaps"), working with the "Modelling tissue and nociceptive stress" Host Team (MATN IFR 150), were interested in studying the illusions described by many patients under regional anaesthetic.

20 Jan 2011

Model guides creation of more patient-centered personal health records

Personal health records have great potential to help patients manage their health, but technology needs to be designed with the patient in mind - which means doing more than helping patients access health information, according to an editorial by two Virginia Commonwealth University family medicine physicians published in the Jan.19 issue of the Journal of the American Medical Association.

20 Jan 2011

Practical Radiation Oncology first issue published

The American Society for Radiation Oncology (ASTRO) is pleased to announce it has published its first issue of Practical Radiation Oncology (PRO), a new medical journal whose mission is to improve the quality of radiation oncology practice. Published by leading scientific publisher Elsevier, the issue is both available in print and online at www.practicalradonc.org.

20 Jan 2011

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Waters Corporation today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry Headquarters in Wilmslow, Cheshire, near Manchester, U.K.

20 Jan 2011

Research News and Research

Clinical Immunology Research Laboratory at The Mount Sinai Medical Center receives Octapharma grant

ESHRE publishes position paper on intrafamilial medically assisted reproduction

Breastfeeding can partially offset long-term side effects of cancer treatment

Ingenix announces formation of new Life Sciences division

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

Damaged alpha-synuclein proteins can spread in a 'prion-like' manner: Study

CHI responds to FDA recommendations for 510(k) regulatory review process

NMDP selects Velos to supply new Product Fulfillment and CDR System

Merck provides additional information about DSMB recommendations for vorapaxar TRA-2P study

No robust conclusions possible on advantages or disadvantages of PET

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

Long-term use of khat drug decreases self-control, leads to undesirable behaviour: Study

Message of health benefits of moderate drinking are hazardous and extremely dangerous

Brains of migraine sufferers show higher proportion of lesions of brain microvessels

Ultrasound device shows promise in breaking up pulmonary embolisms: Research

FOLOTYN Phase 2 peripheral T-cell lymphoma study results published in Journal of Clinical Oncology

Anaesthetising an arm affects brain activity and rapidly impairs body perception

Model guides creation of more patient-centered personal health records

Practical Radiation Oncology first issue published

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News